{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T04:15:39Z","timestamp":1776485739593,"version":"3.51.2"},"reference-count":16,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[1995,7,1]],"date-time":"1995-07-01T00:00:00Z","timestamp":804556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[1995,7]]},"DOI":"10.1016\/s0002-9149(05)80033-5","type":"journal-article","created":{"date-parts":[[2005,10,19]],"date-time":"2005-10-19T13:38:58Z","timestamp":1129729138000},"page":"122A-125A","source":"Crossref","is-referenced-by-count":78,"special_numbering":"S1","title":["Improvement of myocardial perfusion by short-term fluvastatin therapy in coronary artery disease"],"prefix":"10.1016","volume":"76","author":[{"given":"Hermann W.","family":"Eichst\u00e4dt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herbert","family":"Esk\u00f6tter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingo","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Holger W.","family":"Amthauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gottfried","family":"Weidinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"suppl II","key":"10.1016\/S0002-9149(05)80033-5_bib1","first-page":"II","article-title":"Endothelial function in human coronary arteries in vivo; focus on hypercholesterolemia","volume":"18","author":"Drexler","year":"1991","journal-title":"Hypertension"},{"key":"10.1016\/S0002-9149(05)80033-5_bib2","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1056\/NEJM199111283252205","article-title":"The effect of atherosclerosis on the vasomotor response of coronary arteries to mental stress","volume":"325","author":"Yeung","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/S0002-9149(05)80033-5_bib3","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/0140-6736(91)92372-9","article-title":"Correction of endothelial dysfunction tion in coronary microcirculation of hypercholesterolaemic patients by l-arginine","volume":"338","author":"Drexler","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/S0002-9149(05)80033-5_bib4","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1016\/0140-6736(93)90634-S","article-title":"Beneficial effect of cholesterol-lowering therapy on coronary endothelium-dependent relaxation in hypercholesterolaemic patients","volume":"341","author":"Leung","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/S0002-9149(05)80033-5_bib5","first-page":"180","article-title":"Computer-assisted evaluation of ischemic defects in the 201-thallium myocardial scintigraphy","volume":"2","author":"Eichstaedt","year":"1981","journal-title":"Adv Clin Cardiol"},{"key":"10.1016\/S0002-9149(05)80033-5_bib6","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0140-6736(90)91656-U","article-title":"Can lifestyle changes reverse coronary heart disease?","volume":"336","author":"Ornish","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/S0002-9149(05)80033-5_bib7","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1136\/bmj.308.6925.367","article-title":"By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease?","volume":"308","author":"Law","year":"1994","journal-title":"BMJ"},{"key":"10.1016\/S0002-9149(05)80033-5_bib8","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1056\/NEJM199011083231901","article-title":"Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B","volume":"323","author":"Brown","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/S0002-9149(05)80033-5_bib9","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1001\/jama.1990.03450230049028","article-title":"Beneficial effects of colestipol-niacin on coronary atherosclerosis. A four-year follow-up","volume":"264","author":"Cashin-Hemphill","year":"1990","journal-title":"JAMA"},{"key":"10.1016\/S0002-9149(05)80033-5_bib10","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1161\/01.CIR.69.2.313","article-title":"Effects of therapy with cholestyramine on progression of coronary atherosclerosis: results of the NHLBI type II coronary intervention study","volume":"69","author":"Brensike","year":"1984","journal-title":"Circulation"},{"key":"10.1016\/S0002-9149(05)80033-5_bib11","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/0140-6736(92)90863-X","article-title":"Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St. Thomas' Atherosclerosis Regression Study (STARS)","volume":"339","author":"Watts","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/S0002-9149(05)80033-5_bib12","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1161\/01.CIR.87.6.1781","article-title":"Lipid lowering and plaque regression; new insights into prevention of plaque disruption and clinical events in coronary disease","volume":"87","author":"Brown","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/S0002-9149(05)80033-5_bib13","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1161\/01.CIR.89.6.2519","article-title":"Reduction in serum cholesterol with pravastatin improves endothelium-dependent coronary vasomotion in patients with hypercholesterolemia","volume":"89","author":"Egashira","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/S0002-9149(05)80033-5_bib14","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1172\/JCI116634","article-title":"Endothelium-mediated coronary blood flow modulation in humans; effects of age, atherosclerosis, hypercholesterolemia, and hypertension","author":"Zeiher","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1016\/S0002-9149(05)80033-5_bib15","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1161\/01.CIR.85.5.1927","article-title":"Atherosclerosis of lipoprotein-induced endothelial dysfunction; potential mechanisms underlying reduction in EDRF\/nitric oxide activity","volume":"85","author":"Flavahan","year":"1992","journal-title":"Circulation"},{"key":"10.1016\/S0002-9149(05)80033-5_bib16","doi-asserted-by":"crossref","first-page":"117A","DOI":"10.1016\/S0002-9149(05)80032-3","article-title":"Is endothelial dysfunction reversible?","volume":"76","author":"Schmieder","year":"1995","journal-title":"Am J Cardiol"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914905800335?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914905800335?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,21]],"date-time":"2019-01-21T13:28:50Z","timestamp":1548077330000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914905800335"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,7]]},"references-count":16,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[1995,7]]}},"alternative-id":["S0002914905800335"],"URL":"https:\/\/doi.org\/10.1016\/s0002-9149(05)80033-5","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[1995,7]]}}}